EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD

Ryan Kanai, Emily Norton iD, Patrick Stern, Richard O Hynes iD, John M Lamar iD

Cancers · 20.02.2024 · 16 (5) · 852

DOI: 10.3390/cancers16050852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 20.02.2024. Verfasst von Ryan Kanai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted therapies are effective cancer treatments when accompanied by accurate diagnostic tests that can help identify patients that will respond to those therapies. The YAP/TAZ-TEAD axis is activated and plays a causal role in several cancer types, and TEAD inhibitors are currently in early-phase clinical trials in cancer patients. However, a lack of a reliable way to identify tumors with YAP/TAZ-TEAD activation for most cancer types makes it difficult to determine which tumors will be susceptible to TEAD inhibitors. Here, we used a combination of RNA-seq and bioinformatic analysis of metastatic melanoma cells to develop a YAP/TAZ gene signature. We found that the genes in this signature are TEAD-dependent in several melanoma cell lines, and that their expression strongly correlates with YAP/TAZ activation in human melanomas. Using DepMap dependency data, we found that this YAP/TAZ signature was predictive of melanoma cell dependence upon YAP/TAZ or TEADs. Importantly, this was not limited to melanoma because this signature was also predictive when tested on a panel of over 1000 cancer cell lines representing numerous distinct cancer types. Our results suggest that YAP/TAZ gene signatures like ours may be effective tools to predict tumor cell dependence upon YAP/TAZ-TEAD, and thus potentially provide a means to identify patients likely to benefit from TEAD inhibitors.

Schlagwörter

Stichwörter der Autor:innen

HippoTAZTEADWWTR1YAPgene signaturemelanomametastasis

Autor:innen und Institutionen

  • Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA.
  • Koch Institute for Integrative Cancer Research, at Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Department of Biology, Koch Institute for Integrative Cancer Research, and Howard Hughes Medical Institute, at Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

ORCID-Profile: Emily Norton, Richard O Hynes, John M Lamar

Förderung

  • NIH HHS
  • NCI NIH HHS
  • Howard Hughes Medical Institute
  • National Institutes of Health (NIH) National Research Service Award
  • Koch Institute Frontier Research Fund
  • Albany Medical College Dean’s Office Bridge Grant
  • NCI
  • NIH Tumor Microenvironment Network

Zitieren

APA

Kanai, R., Norton, E., Stern, P., Hynes, R. O., & Lamar, J. M. (2024). Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD. Cancers, 16(5), 852. https://doi.org/10.3390/cancers16050852

Vancouver

Kanai R, Norton E, Stern P, Hynes RO, Lamar JM. Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD. Cancers. 2024;16(5):852. doi:10.3390/cancers16050852

BibTeX
@article{Kanai2024,
  author = {Kanai, Ryan and Norton, Emily and Stern, Patrick and Hynes, Richard O and Lamar, John M},
  title = {Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {5},
  pages = {852},
  doi = {10.3390/cancers16050852}
}
Kostenlos starten →